Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy
Open accessThe DOI matches its Crossref record; 79 of the 79 references it cites were found in a registry or an index.
Abstract
Selective serotonin reuptake inhibitors (SSRIs) and internet-based cognitive behavioral therapy (ICBT) are recommended treatments of social anxiety disorder (SAD), and often combined, but their effects on monoaminergic signaling are not well understood. In this multi-tracer positron emission tomography (PET) study, 24 patients with SAD were randomized to treatment with escitalopram+ICBT or placebo+ICBT under double-blind conditions. Before and after 9 weeks of treatment, patients were examined with positron emission tomography and the radioligands [ 11 C]DASB and [ 11 C]PE2I, probing the serotonin (SERT) and dopamine (DAT) transporter proteins respectively. Both treatment combinations resulted in significant improvement as measured by the Liebowitz Social Anxiety Scale (LSAS). At baseline, SERT-DAT co-expression was high and, in the putamen and thalamus, co-expression showed positive associations with symptom severity. SERT-DAT co-expression was also predictive of treatment success, but predictor-outcome associations differed in direction between the treatments. After treatment, average SERT occupancy in the SSRI + ICBT group was >80%, with positive associations between symptom improvement and occupancy in the nucleus accumbens, putamen and anterior cingulate cortex. Following placebo+ICBT, SERT binding increased in the raphe nuclei. DAT binding increased in both groups in limbic and striatal areas, but relations with symptom improvement differed, being negative for SSRI + ICBT and positive for placebo + ICBT. Thus, serotonin-dopamine transporter co-expression exerts influence on symptom severity and remission rate in the treatment of social anxiety disorder. However, the monoamine transporters are modulated in dissimilar ways when cognitive-behavioral treatment is given concomitantly with either SSRI-medication or pill placebo.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The cited source doesn’t support the claim as written.
In the citing paper
“In the SSRI + CBT group, reduced anxiety correlated with increased striatal serotonin transporter binding, but not with blood drug concentration.”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Hjorth et al., 2022
Checked by a reasoning model — may be wrong.
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“In yet another study, combining SSRIs with cognitive-behavioral therapy (CBT) led to more robust and longer-lasting outcomes than placebo combined with CBT, with distinct effects on brain monoamine transporters.”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Hjorth et al., 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Decreased dopamine transporter availability in the nucleus accumbens and left thalamus correlated with reduced social anxiety, whereas an opposite correlation was observed in the placebo + CBT group (Hjorth et al., 2022).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Hjorth et al., 2022
Experimental — accuracy not yet measuredThe source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“Treatment results showed that both the escitalopram + CBT and placebo + CBT combinations yielded significant improvement (p < 0.001), with social anxiety symptom assessments on the LSAS-SR decreasing by 37 and 24 points, respectively (Hjorth et al., 2022).”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Hjorth et al., 2022
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“No serotonin reuptake inhibition was seen after placebo + CBT; on the contrary, serotonin transporter availability increased in the raphe nuclei.”
From Revisiting the SSRI vs. placebo debate in the treatment of social anxiety disorder: the role of expectancy effects, neural responsivity, and monoamine transporters (2025) · cites this paper as Hjorth et al., 2022
1 more claim about this paper
Create a free account to see every claim other papers make about this one.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
A new depression scale designed to be sensitive to change
Montgomery, S. A., & Åsberg, M. (1979) · British Journal of Psychiatry · doi:10.1192/bjp.134.4.382 · Cited by 13,962
(1998) · PubMed · Cited by 10,216
Maldjian, J. A., Laurienti, P. J., Kraft, R. A., & Burdette, J. H. (2003) · NeuroImage · doi:10.1016/s1053-8119(03)00169-1 · Cited by 5,085
Wang, P. S., Lane, M., Olfson, M., Pincus, H. A., Wells, K. B., & Kessler, R. C. (2005) · Archives of General Psychiatry · doi:10.1001/archpsyc.62.6.629 · Cited by 2,695 · cited 1×
“INTRODUCTION Social anxiety disorder (SAD) is a debilitating and chronic psychiatric disorder associated with severe suffering for the individual, negative impact on working-life and relationships [1] and high barriers to seek treatment [2].”
BackgroundDistribution Volume Ratios without Blood Sampling from Graphical Analysis of PET Data
Logan, J., Fowler, J. S., Volkow, N. D., Wang, G.-J., Ding, Y.-S., & Alexoff, D. L. (1996) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1097/00004647-199609000-00008 · Cited by 1,514
Hammers, A., Allom, R., Koepp, M. J., Free, S. L., Myers, R., Lemieux, L., Mitchell, T. N., Brooks, D. J., & Duncan, J. S. (2003) · Human Brain Mapping · doi:10.1002/hbm.10123 · Cited by 1,286
Carlbring, P., Andersson, G., Cuijpers, P., Riper, H., & Hedman-Lagerlöf, E. (2018) · Cognitive Behaviour Therapy · doi:10.1080/16506073.2017.1401115 · Cited by 1,232
Self-citationStein, M. B., & Stein, D. J. (2008) · The Lancet · doi:10.1016/s0140-6736(08)60488-2 · Cited by 1,137
Parametric Imaging of Ligand-Receptor Binding in PET Using a Simplified Reference Region Model
Gunn, R. N., Lammertsma, A. A., Hume, S. P., & Cunningham, V. J. (1997) · NeuroImage · doi:10.1006/nimg.1997.0303 · Cited by 1,084
Pharmacokinetics of selective serotonin reuptake inhibitors
Hiemke, C., & Härtter, S. (2000) · Pharmacology & Therapeutics · doi:10.1016/s0163-7258(99)00048-0 · Cited by 883
Research works printed but not linked: 2
- First MB, Spitzer RL, Gibbon MB, Williams J. Structured clinical interview for DSM-IV axis i disorders – non-patient edition. New York: New York State Psychiatric Institute. 1997.
- Clark DM, Wells A. A cognitive model of social anxiety. In: Heimberg RG, Liebowitz MR, Hope DA, Schneier FR, editors. Social phobia: diagnosis, assessment and treatment. Guilford Press: New York, NY, 1995, pp 69–93.
Cited by
Cai, X., Wu, M., Zhang, Z., Liu, H., Huang, S., Song, J., Ren, S., & Huang, Y. (2023) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.14200 · Cited by 28
Hart, X. M., Spangemacher, M., Defert, J., Uchida, H., & Gründer, G. (2024) · Therapeutic Drug Monitoring · doi:10.1097/ftd.0000000000001142 · Cited by 14
Sun, H., Bian, H., Wang, Y., yu, S., Wu, Y., & Huang, L. (2026) · International Journal of General Medicine · doi:10.2147/ijgm.s594224 · Cited by 6
Andreoli, G., Kasch, C., Lindsay, C. E., & Hofmann, S. G. (2026) · Expert Review of Neurotherapeutics · doi:10.1080/14737175.2025.2604303 · Cited by 2
Wang, Y., Zhou, J., Chen, X., Liu, R., Zhang, Z., Feng, Y., Zhou, Y., & Wang, G. (2025) · NeuroImage Clinical · doi:10.1016/j.nicl.2025.103842 · Cited by 2
Metadata
- Authors
- Hjorth, O., Frick, A., Gingnell, M., Engman, J., Björkstrand, J., Faria, V., Alaie, I., Carlbring, P., Andersson, G., Jonasson, M., Lubberink, M., Antoni, G., Reis, M., Wahlstedt, K., Fredrikson, M., & Furmark, T.
- Affiliations
- Uppsala University (SE)
- Lund University (SE)
- Boston Children's Hospital (US)
- Stockholm University (SE)
- Linköping University (SE)
- Corresponding author
- Hjorth, Olof
- ORCID
- Venue
- Translational Psychiatry
- Published
- 2022-10-07
- Volume
- 12
- Issue
- 1
- Pages
- 436-436
- ISSN
- 2158-3188 (ISSN-L)
- PMC
- PMC9537299
- OpenAlex
- W4302774148
- Cited by
- 13
- References
- 79
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 1 · 2023: 2
- FWCI
- 2.07
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0 (tdm)
- creativecommons.org/licenses/by/4.0 (vor)
- Locations
- Translational Psychiatry (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DiVA (Linkoping University) (submittedVersion, other-oa)
- Uppsala University Publications (Uppsala University) (submittedVersion, other-oa)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Lund University Publications (Lund University) (submittedVersion)
- Funders
- Vetenskapsrådet
- Hjärnfonden
- Riksbankens Jubileumsfond
- Topics
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment
- Keywords
- social anxiety disorder, serotonin transporter, dopamine transporter, escitalopram, internet-based cognitive behavioral therapy, combined psychotherapy and pharmacotherapy, monoaminergic signaling, treatment response prediction, [11C]DASB, [11C]PE2I, nucleus accumbens, putamen, thalamus, raphe nuclei, striatum
- MeSH terms
- Phobia, Social, Escitalopram, Brain, Dopamine, Humans, Serotonin, Cognitive Behavioral Therapy, Selective Serotonin Reuptake Inhibitors, Dopamine Plasma Membrane Transport Proteins, Serotonin Plasma Membrane Transport Proteins
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy. https://app.cochat.ai/papers/10.1038/s41398-022-02187-3
- The paper
- Hjorth, O., Frick, A., Gingnell, M., Engman, J., Björkstrand, J., Faria, V., Alaie, I., Carlbring, P., Andersson, G., Jonasson, M., Lubberink, M., Antoni, G., Reis, M., Wahlstedt, K., Fredrikson, M., & Furmark, T. (2022). Serotonin and dopamine transporter availability in social anxiety disorder after combined treatment with escitalopram and cognitive-behavioral therapy. Translational Psychiatry. https://doi.org/10.1038/s41398-022-02187-3
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.